Dr. Shamir Mehta, MD
Claim this profileHamilton Health Sciences
Studies Tricuspid Regurgitation
Studies Hemorrhage
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Shamir Mehta, MD is currently running
Edwards PASCAL System
for Tricuspid Regurgitation
This trial tests a new device that fixes a leaky heart valve without surgery in patients who are too risky for traditional surgery. The device helps the valve close properly to stop blood from leaking backward. The first device specifically designed for this purpose is the paravalvular leak device (PLD - Occlutech).
Recruiting1 award N/A6 criteria
Heparin
for Heart Disease
Patients undergoing cardiac catheterization will be randomized to 3 groups: no anticoagulant, low dose anticoagulant and high dose anticoagulant.
Recruiting3 awards Phase 33 criteria
More about Shamir Mehta, MD
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Shamir Mehta, MD has experience with
- Bentracimab (PB2452)
- Heparin
- Placebos
- Implantable Cardioverter Defibrillator
- Edwards PASCAL System
- Optimal Medical Therapy
Breakdown of trials Shamir Mehta, MD has run
Tricuspid Regurgitation
Emergency Surgery
Invasive Procedure
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shamir Mehta, MD specialize in?
Shamir Mehta, MD focuses on Tricuspid Regurgitation and Hemorrhage. In particular, much of their work with Tricuspid Regurgitation has involved treating patients, or patients who are undergoing treatment.
Is Shamir Mehta, MD currently recruiting for clinical trials?
Yes, Shamir Mehta, MD is currently recruiting for 2 clinical trials in Hamilton Ontario. If you're interested in participating, you should apply.
Are there any treatments that Shamir Mehta, MD has studied deeply?
Yes, Shamir Mehta, MD has studied treatments such as Bentracimab (PB2452), Heparin, Placebos.
What is the best way to schedule an appointment with Shamir Mehta, MD?
Apply for one of the trials that Shamir Mehta, MD is conducting.
What is the office address of Shamir Mehta, MD?
The office of Shamir Mehta, MD is located at: Hamilton Health Sciences Centre, Hamilton, Ontario L8L 2X2 Canada. This is the address for their practice at the Hamilton Health Sciences Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.